Cargando…

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα

Hepcidin is the principal iron regulatory hormone, controlling the systemic absorption and remobilization of iron from intracellular stores. Recent in vivo studies have shown that hepcidin is down-regulated by erythropoiesis, anemia, and hypoxia, which meets the need of iron input for erythrocyte pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Jorge P., Ribeiro, Sara, Pontes, Helena, Thowfeequ, Shifaan, Tosh, David, Carvalho, Félix, Porto, Graça
Formato:	Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2008
Materias:	RED CELLS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597200/ https://www.ncbi.nlm.nih.gov/pubmed/18326822 http://dx.doi.org/10.1182/blood-2007-08-106195

Ejemplares similares

Stem cells in the adult pancreas and liver
por: Burke, Zoë D., et al.
Publicado: (2007)

Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children
por: Prentice, Andrew M., et al.
Publicado: (2012)

Embryonic and extraembryonic tissues during mammalian development: shifting boundaries in time and space
por: Thowfeequ, Shifaan, et al.
Publicado: (2022)

Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice
por: Nakai, Taku, et al.
Publicado: (2023)

Erythropoietin drives breast cancer progression by activation of its receptor EPOR
por: Chan, Ka Kui, et al.
Publicado: (2017)

Maurer's clefts of Plasmodium falciparum are secretory organelles that concentrate virulence protein reporters for delivery to the host erythrocyte
por: Bhattacharjee, Souvik, et al.
Publicado: (2008)

Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A
por: Toye, Ashley M., et al.
Publicado: (2008)

Effects of age-dependent membrane transport changes on the homeostasis of senescent human red blood cells
por: Lew, Virgilio L., et al.
Publicado: (2007)

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states
por: BRUGNARA, C, et al.
Publicado: (2006)

A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin
por: Oskarsson, Gudjon R., et al.
Publicado: (2018)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models
por: Wang, Jieyu, et al.
Publicado: (2018)

Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice
por: Poli, Maura, et al.
Publicado: (2019)

Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia
por: Kumkhaek, Chutima, et al.
Publicado: (2008)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2007)

Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease
por: Vichinsky, Elliott, et al.
Publicado: (2011)

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises
por: Krishnan, Suba, et al.
Publicado: (2010)

Transfer of 4-hydroxynonenal from parasitized to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia
por: Uyoga, Sophie, et al.
Publicado: (2012)

Efficacy and safety of deferasirox doses of >30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload
por: Taher, Ali, et al.
Publicado: (2009)

Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness
por: Makani, Julie, et al.
Publicado: (2009)

Haptoglobin, alpha‐thalassaemia and glucose‐6‐phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania
por: Cox, Sharon E., et al.
Publicado: (2014)

Cytoadherence in paediatric malaria: ABO blood group, CD36, and ICAM1 expression and severe Plasmodium falciparum infection
por: Cserti-Gazdewich, Christine M, et al.
Publicado: (2012)

Epistasis and the sensitivity of phenotypic screens for beta thalassaemia
por: Penman, Bridget S, et al.
Publicado: (2015)

Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania
por: Makani, Julie, et al.
Publicado: (2015)

The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels
por: Patel, Neeta, et al.
Publicado: (2014)

An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
por: Carrancio, Soraya, et al.
Publicado: (2014)

Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins
por: Yang, Cheng-Tao, et al.
Publicado: (2014)

A novel 33‐Gene targeted resequencing panel provides accurate, clinical‐grade diagnosis and improves patient management for rare inherited anaemias
por: Roy, Noémi B. A., et al.
Publicado: (2016)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia
por: Hannemann, Anke, et al.
Publicado: (2018)

Quantitative sensory testing in children with sickle cell disease: additional insights and future possibilities
por: Miller, Robin E., et al.
Publicado: (2019)

Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study
por: Kanter, Julie, et al.
Publicado: (2018)

MIR29B mediates epigenetic mechanisms of HBG gene activation
por: Starlard‐Davenport, Athena, et al.
Publicado: (2019)

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis
por: Socié, Gérard, et al.
Publicado: (2019)

Safety and benefits of interventions to increase folate status in malaria‐endemic areas
por: Verhoef, Hans, et al.
Publicado: (2017)

Safety and benefits of antenatal oral iron supplementation in low‐income countries: a review
por: Mwangi, Martin N., et al.
Publicado: (2017)

Deficit of circulating CD19(+)CD24(hi)CD38(hi) regulatory B cells in severe aplastic anaemia
por: Zaimoku, Yoshitaka, et al.
Publicado: (2020)

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study
por: Jang, Jun Ho, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies
por: Peffault de Latour, Régis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e7b1e9n5bu3gne1kqc97dlibkn